KRAS and pancreatic neoplasm: Interestingly, it is unusual to find mutations of SMAD4, TP53, and KRAS, and it is probable that the STK1/LKB1 silencing follows a different mechanism from that found in sporadic cases to produce pancreatic cancer [249].